Onur Boyman

Onur Boyman

Universität Zürich

H-index: 58

Europe-Switzerland

About Onur Boyman

Onur Boyman, With an exceptional h-index of 58 and a recent h-index of 45 (since 2020), a distinguished researcher at Universität Zürich, specializes in the field of Immunology.

His recent articles reflect a diverse array of research interests and contributions to the field:

Immune dysregulation in long COVID

In vitro and in vivo Evaluation of Chemically Synthesized, Receptor-Biased Interleukin-4 and Photocaged Variants

Optimising IL-2 for cancer immunotherapy

Persistent complement dysregulation with signs of thromboinflammation in active Long Covid

IL-2 immunotherapy rescues irradiation-induced T cell exhaustion in vivo

Autoantibodies against chemokines post-SARS-CoV-2 infection correlate with disease course

A systematic review of interleukin-2-based immunotherapies in clinical trials for cancer and autoimmune diseases

Comprehensive analysis of human IL‐4 receptor subunits shows compartmentalization in steady state and dupilumab treatment

Onur Boyman Information

University

Position

Department of Immunology University Hospital Zurich

Citations(all)

16725

Citations(since 2020)

8112

Cited By

11414

hIndex(all)

58

hIndex(since 2020)

45

i10Index(all)

102

i10Index(since 2020)

99

Email

University Profile Page

Google Scholar

Onur Boyman Skills & Research Interests

Immunology

Top articles of Onur Boyman

Immune dysregulation in long COVID

Nature Immunology

2024/4/8

Onur Boyman
Onur Boyman

H-Index: 39

In vitro and in vivo Evaluation of Chemically Synthesized, Receptor-Biased Interleukin-4 and Photocaged Variants

2024/3/26

Onur Boyman
Onur Boyman

H-Index: 39

Optimising IL-2 for cancer immunotherapy

2024/2

Onur Boyman
Onur Boyman

H-Index: 39

Persistent complement dysregulation with signs of thromboinflammation in active Long Covid

Science

2024/1/19

IL-2 immunotherapy rescues irradiation-induced T cell exhaustion in vivo

bioRxiv

2024

Irma Telarovic
Irma Telarovic

H-Index: 3

Onur Boyman
Onur Boyman

H-Index: 39

A systematic review of interleukin-2-based immunotherapies in clinical trials for cancer and autoimmune diseases

2023/4/1

Ufuk Karakus
Ufuk Karakus

H-Index: 9

Onur Boyman
Onur Boyman

H-Index: 39

Comprehensive analysis of human IL‐4 receptor subunits shows compartmentalization in steady state and dupilumab treatment

Allergy

2023/4

Onur Boyman
Onur Boyman

H-Index: 39

Biased IL-2 signals induce Foxp3-rich pulmonary lymphoid structures and facilitate long-term lung allograft acceptance in mice

Nature Communications

2023/3/13

Publisher Correction: Human memory B cells show plasticity and adopt multiple fates upon recall response to SARS-CoV-2

Nature Immunology

2023

Treg-selective IL-2 starvation synergizes with CD40 activation to sustain durable responses in lymphoma models

Journal for Immunotherapy of Cancer

2023

Molecular states during acute COVID-19 reveal distinct etiologies of long-term sequelae

Nature Medicine

2023/1

Immune-stimulating humanized monoclonal antibodies against human interleukin-2, and fusion proteins thereof

2023/12/26

Tumor cell–intrinsic c-Myb upregulation stimulates antitumor immunity in a murine colorectal cancer model

Cancer Immunology Research

2023/10/4

A cd25-biased anti-il-2 antibody

2023/9/28

Human memory B cells show plasticity and adopt multiple fates upon recall response to SARS-CoV-2

Nature Immunology

2023/6

Low-dose interleukin-2 for the treatment of systemic lupus erythematosus: A systematic review and meta-analysis

2022/12/4

Onur Boyman
Onur Boyman

H-Index: 39

Mechanisms regulating neutrophil responses in immunity, allergy, and autoimmunity

2022/12

Onur Boyman
Onur Boyman

H-Index: 39

See List of Professors in Onur Boyman University(Universität Zürich)

Co-Authors

academic-engine